11/17/2023
Breaking News: FDA Approves Enzalutamide as a Treatment Option for Patients with Recurrent Prostate Cancer at High Risk of Metastases
Patients who have been treated for localized prostate cancer and are now seeing their PSA rise rapidly are at high risk of metastasis and of death from prostate cancer. Now, patients and their doctors have a new treatment option that decreases these risks. The FDA has approved enzalutamide alone OR. Read More
11/09/2023
Staying Active, Staying Positive
Two and a half years ago, David Atkinson described his journey with advanced prostate cancer. A West Point graduate and Army veteran, he was treated by PCF-funded researcher and medical oncologist Dr. Julie Graff at the PCF-VA Center of Excellence in Portland. When David’s cancer didn’t respond to standard treatment. Read More
Unsubscription confirmation
You've been successfully unsubscribed from the Prostate Cancer Foundation Email List. We're sorry to see you go, please feel free to join back again anytime. Read More
Already Subscribed
You were already subscribed to this list. We're happy to have you in the Prostate Cancer Foundation Community! Read More
Subscription Confirmation
You are now subscribed to the Prostate Cancer Foundation Email List. As an email subscriber, you will hear from us 1 to 2 times a month with the latest news about prostate cancer. Read More
10/24/2023
The Prostate Cancer Foundation Announces The 2023 Young Investigator Awards Totaling More Than $6 Million for Prostate Cancer Research
LOS ANGELES, Calif., October 24, 2023 – The Prostate Cancer Foundation (PCF) today announced the Class of 2023 Young Investigator Award recipients totaling $6.1 million in funding for innovative prostate cancer research. PCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the. Read More
10/24/2023
Young Investigator Award- Class of 2023
The PCF Young Investigator Award-Class of 2023 recipients are: 2023 Lowell Milken - PCF Young Investigator Award MMUVE Prostate Cancer: Multi-Omic Evaluation of Micro-Ultrasound VisiblE Prostate Cancer Wayne Brisbane, MD University of California, Los Angeles Mentors: Leonard Marks MD, Robert Reiter MD, Paul Boutros PhD Description: Diagnosis of prostate cancer. Read More
10/23/2023
Being Proactive Care Partners in the Prostate Cancer Journey, Part 2
In this two-part series, guest author Susan Dresner shares her personal perspective based on her own experience caring for her partner with prostate cancer and on her interactions with many other care-partners. In this section, Susan offers resources and suggestions to help care-partners sustain themselves as they embark and continue. Read More
10/23/2023
Being Proactive Care Partners in the Prostate Cancer Journey, Part 1
In this two-part series, guest author Susan Dresner shares her personal perspective based on her own experience caring for her partner with prostate cancer and on her interactions with many other care-partners. Like many, I was unprepared for caregiving when my partner was diagnosed with stage 4 prostate cancer. In. Read More
10/20/2023
Hormone Therapy: Be FIERCE with Exercise
Hormone therapy (also known as androgen deprivation therapy, ADT) can do a lot of good: in men with high-risk prostate cancer, for example, a two-year course of ADT can make the cancer more susceptible to radiation treatment, leading to a cure. And in men with cancer that has spread beyond. Read More